V029-2613 Screening compound: 5-(4-tert-butylbenzamido)-1-propyl-N-[2-(pyridin-2-yl)ethyl]-1H-indole-2-carboxamide

V029-2613 Screening compound: 5-(4-tert-butylbenzamido)-1-propyl-N-[2-(pyridin-2-yl)ethyl]-1H-indole-2-carboxamide
V029-2613 Screening compound: 5-(4-tert-butylbenzamido)-1-propyl-N-[2-(pyridin-2-yl)ethyl]-1H-indole-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V029-2613
5-(4-tert-butylbenzamido)-1-propyl-N-[2-(pyridin-2-yl)ethyl]-1H-indole-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V029-2613

Molecular Formula

C30H34N4O2 (C30 H34 N4 O2)

Compound Name

5-(4-tert-butylbenzamido)-1-propyl-N-[2-(pyridin-2-yl)ethyl]-1H-indole-2-carboxamide

IUPAC name

5-(4-tert-butylbenzamido)-1-propyl-N-[2-(pyridin-2-yl)ethyl]-1H-indole-2-carboxamide

SMILES

CCCn(c(C(NCCc1ncccc1)=O)c1)c(cc2)c1cc2NC(c1ccc(C(C)(C)C)cc1)=O

InChI

InChI=1S/C30H34N4O2/c1-5-18-34-26-14-13-25(33-28(35)21-9-11-23(12-10-21)30(2,3)4)19-22(26)20-27(34)29(36)32-17-15-24-8-6-7-16-31-24/h6-14,16,19-20H,5,15,17-18H2,1-4H3,(H,32,36)(H,33,35)

InChI Key

XBSSQTFDDZZIMP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19778398

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

482.63

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

6.026

Distribution Coefficient, logD

6.026

Water Solubility, LogSw

-5.34

Polar Surface Area

57.832

Acid Dissociation Constant (pKa)

11.72

Base Dissociation Constant (pKb)

4.06

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.00

V029-2613 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

ACE2 Library (3043 compounds)

GPCR Targeted Library (31838 compounds)

Indole Derivatives (10091 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Cyclic compounds
Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V029-2613 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V029-2613?
Check Price and Availability of V029-2613, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V029-2613 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V029-2613
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V029-2613
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V029-2613 available by request